Efficiency of refresher courses of systemic (89SrCL2) radiotherapy for metastatic prostate cancer
https://doi.org/10.17650/1726-9776-2006-2-2-61-63
Abstract
For patients with metastatic prostate cancer, palliative treatment is largely based on relief of skeletal pain. To evaluate a palliative effect and to reveal the positive and negative effects of a refresher course of systemic radiotherapy with strontium-89 chloride (89SrCl2), the authors assessed the results of comprehensive examination and the parameters of life quality in patients with metastatic prostate cancer who had taken 2—3 courses of systemic (89SrCl2) radiotherapy.
About the Authors
Ye. N. KiselevRussian Federation
Saint Petersburg
L. I. Korytova
Russian Federation
Saint Petersburg
M. I. Karelin
Russian Federation
Saint Petersburg
Review
For citations:
Kiselev Ye.N., Korytova L.I., Karelin M.I. Efficiency of refresher courses of systemic (89SrCL2) radiotherapy for metastatic prostate cancer. Cancer Urology. 2006;2(2):61-63. (In Russ.) https://doi.org/10.17650/1726-9776-2006-2-2-61-63